- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MRI Predicts Recurrence-Free Survival in Breast Cancer
MRI can help physicians predict breast cancer recurrence in women who underwent chemotherapy and surgery.
MRI may help predict recurrence-free survival (RFS) in women with breast cancer, even in the presence of pathologic complete response (PCR) and residual cancer burden (RCB) class, according to a study published in Radiology.
Researchers from California, Rhode Island, Pennsylvania, Washington, Alabama, South Carolina, New York, Texas, Washington DC, and Illinois, performed a prospective multicenter study to evaluate volumetric MR imaging for predicting RFS after neoadjuvant chemotherapy (NACT) of breast cancer and to consider its predictive performance relative to PCR.
The study included 162 female patients with breast tumors that were 3 cm or larger. The women were scheduled to receive NACT. They underwent four examinations with dynamic contrast-enhanced MR imaging:
1. Before NACT treatment began
2. After one cycle
3. Midtherapy
4. Before surgery[[{"type":"media","view_mode":"media_crop","fid":"47312","attributes":{"alt":"MRI","class":"media-image media-image-right","id":"media_crop_8651781788049","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5555","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 135px; width: 180px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"©nav/Shutterstock.com","typeof":"foaf:Image"}}]]
The researchers determined functional tumor volume (FTV), computed from MR images by using enhancement thresholds, and change from baseline (ÎFTV) were measured after one cycle and before surgery.
The results showed that FTV2, FTV4, and ÎFTV4 had significant association with RFS, as did HR/HER2 status and RCB class. “PCR approached significance at univariate analysis and was not significant at multivariate analysis,” the authors wrote.
The FTV2 and RCB class had the strongest predictive performance, greater than for FTV4 and PCR. At multivariate analysis, a model with FTV2, ÎFTV2, RCB class, HR/HER2 status, age, and race had the highest C statistic (0.72; 95% CI: 0.60, 0.84).
The researchers concluded that using MR imaging to measure breast tumor FTV is a strong predictor for RFS.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.
